Rep. Kevin Hern Reports Trades in Apple and Boston Scientific
Oklahoma Rep. Kevin Hern disclosed multiple stock trades involving Apple and Boston Scientific, drawing renewed scrutiny of congressional investing.
Rep. Kevin Hern, who represents Oklahoma's 1st congressional district, disclosed multiple stock trades involving shares of Apple Inc. and Boston Scientific, according to a report from All News. The transactions add Hern's name to a growing list of lawmakers whose personal investment activity has attracted public attention in recent years.
Hern's trades span two prominent publicly traded companies operating in distinctly different sectors. Apple, the Cupertino-based technology giant, is among the most widely held stocks in the country, while Boston Scientific is a major player in the medical device industry. The combination of trades across both sectors raises questions familiar to ethics watchdogs who monitor congressional financial disclosures.
Read more Stocks Waver Amid Bond Market's Monthly Decline →
Federal law requires members of Congress to publicly disclose stock transactions under the Stop Trading on Congressional Knowledge Act, commonly known as the STOCK Act, enacted in 2012. The law was designed to prevent lawmakers from using nonpublic information gained through their official duties to inform personal investment decisions. Disclosure filings do not, by themselves, indicate any wrongdoing.
Hern, a Republican businessman first elected in 2018, has served on committees with legislative jurisdiction over sectors relevant to technology and healthcare policy. Critics of congressional stock trading have long argued that even legally compliant trading by sitting lawmakers creates inherent conflicts of interest, regardless of whether inside information was involved. Calls for an outright ban on individual stock ownership by members of Congress have gained bipartisan momentum in recent sessions but have yet to advance to a floor vote.
Continue reading at All News.
